Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Diaryltriazoles as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1

Diaryltriazoles as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1

US Patent 8178546 · Granted May 15, 2012

Estimated economic value: $113,223,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Percutaneous catheter directed intravascular occlusion devices2025
Percutaneous catheter directed intravascular occlusion devices2025
Percutaneous catheter directed intravascular occlusion devices2025
Compositions and methods for the treatment of viral infections2023
Tyrosine-specific functionalized insulin and insulin analogs2022
Metallo-beta-lactamase inhibitors and methods of use thereof2021
Metallo-beta-lactamase inhibitors2020
Metallo-β-lactamase inhibitors2019
Metallo-beta-lactamase inhibitors2019
Inhibitors of the renal outer medullary potassium channel2019
Factor XIa inhibitors2018
Inhibitors of the renal outer medullary potassium channel2018